Successful pregnancy in stage IE primary non-Hodgkin's lymphoma of uterine cervix treated with neoadjuvant chemotherapy and conservative surgery

Oncology
D LorussoG Scambia

Abstract

Primary non-Hodgkin's lymphoma involving the uterine cervix is extremely rare with a frequency of 0.008% of all cervical tumors. No standard treatment has been defined for this disease. A 29-year-old Caucasian woman with primary non-Hodgkin stage IE lymphoma of the uterine cervix was treated with neoadjuvant chemotherapy and conservative surgery. Three years after completion of primary treatment, she became pregnant and successfully delivered a full-term healthy baby. This case report supports the data that a conservative strategy consisting of neoadjuvant chemotherapy followed by a uterine-preserving approach represents an adequate option for young highly motivated patients who desire to preserve the childbearing potential.

References

Aug 1, 1976·Journal of Clinical Pathology·I CarrF F Neal
Nov 11, 1991·Cancer·H G MuntzH M Tarraza
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Jan 1, 1972·Cancer·C FreemanS J Cutler
May 17, 2003·The Hematology Journal : the Official Journal of the European Haematology Association·Patricia Franchi-RezguiPauline Brice
Jun 27, 2003·American Journal of Hematology·W Y AuC Choy
Oct 20, 2006·Gynecologic Oncology·Mauro SignorelliCostantino Mangioni

❮ Previous
Next ❯

Citations

Feb 27, 2009·Nature Reviews. Cancer·Steven Christopher Smith, Dan Theodorescu
Aug 9, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Elisabeth J M RobbeJohanna M A Pijnenborg
Oct 27, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Yang YanYincheng Teng
Jun 16, 2015·Gynecologic Oncology Reports·Elena IgweJames Ferriss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.